Sunday November 22 2009 | Biotechnology feed | All feeds
|
|
TRANXENOGEN, INC
Download detailed PDF Members: TranXenoGen, Inc is a publicly traded biotechnology company listed on the Alternative Investment Market of the London Stock Exchange (TXN.L). The Company is focused on developing new methods for manufacturing therapeutic proteins and a portfolio of products. Its product pipeline includes Anti-Neoplastic Urinary Protein ("ANUP") for the treatment of several types of cancer, Insulin and Human Serum Albumin ("HSA"). The Company believes that its technology platform will have multiple applications including the generation of transgenic chickens for the manufacture of high volume therapeutic proteins, animal models for the study of disease, and high throughput production of antibodies from genomic derived targets for product identification. TranXenoGen is developing its technology platform for the production of generic biologicals (e.g., Insulin and HSA), contract manufacturing of third party products and potential applications in the areas of biodefense and vaccine development. In addition, the Company is exploring licensing of both the technology and products for certain geographic areas and commercial applications.
This page has been viewed 289 times since April 2007, the link to the organisation's website has been followed 69 times Recent Search Terms used to find this page: transxe | . Search for more companies in SHREWSBURY Search for more companies in Massachusetts This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified. BioPortfolio search results for TRANXENOGEN, INC | |||||||||||||||||||||||||||||||||||||||||
|